Figure 2. HDACs in ischemic heart disease.
Both ischemia and ischemia/reperfusion trigger cell death via mechanisms that involve class I HDACs. Inhibition of HDAC activity reduces infarct size. Post-infarct stresses induce cardiomyocyte hypertrophy, cell death (e.g. apoptosis) and fibrosis. Again, HDAC inhibitors are capable of blocking elements of these detrimental biological processes and preserve cardiac function.